Conduction system pacing vs biventricular pacing for CRT
Official title: Nordic-CSP - a Randomized Nordic Study - Is Conduction System Pacing Superior Compared to Conventional BIV-CRT in Reducing the Death or Heart Failure-related Hospitalization in Patients With Heart Failure and Bundle Branch Block?
Run by Copenhagen University Hospital, Rigshospitalet · NCT07492979 · Data updated 2026-11-12
This study tests whether pacing the heart’s conduction system (HIS or left bundle) during CRT works better than standard biventricular pacing for people with heart failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 1100 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 5 sites (Aarhus and 4 other locations) |
| Status | Recruiting |
| Started | June 17, 2026 |
| Main results expected | March 1, 2031 |
| Study ends | July 1, 2031 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07492979 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with symptomatic heart failure, LVEF ≤ 35% (or ≤ 40% with specific CRT indication), NYHA II–IV, optimized medical therapy, and an upgrade or indication for CRT.
✕Probably not a fit
Patients without conduction system abnormalities suitable for CSP or with recent major comorbidities may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Nordic randomized trial compares conduction system pacing (HIS-pacing or left bundle branch pacing) to conventional biventricular CRT in adults with heart failure and reduced ejection fraction. It is blinded for endpoint adjudicators and imaging personnel, with randomization occurring at the time of device implantation and stratified by bundle branch block type and RV pacing. The primary goal is to reduce the composite of death and non-planned heart failure hospitalization. Enrollment spans multiple centers in Denmark, Sweden, Norway, and Finland, with follow-up designed to be equivalent between arms. The study is investigator-initiated and aims to clarify whether CSP can improve outcomes for CRT patients at risk of poor prognosis.
Why it matters
Potential benefit: If successful, patients may experience fewer hospitalizations and deaths related to heart failure due to more physiologic pacing.
How similar studies have gone: Prior CSP studies suggest potential benefits, but definitive, large-scale results for CRT patients remain to be established, making this Nordic trial noteworthy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age, * LVEF ≤ 35%, * NYHA Class II-IV (IV only outpatients), * optimized in medical treatment (OMT) AND one of the following: . LBBB according to AHA/ACC/HRS Scientific Statement from 2009 and ≥130ms or * LBBB-like intraventricular conduction delay (IVCD) \> 150ms or RV paced QRS and indication for upgrade to CRT (\> 40% RV pacing) OR * ≥18 years of age, * LVEF ≤ 40 % * pacing indicated by AV-block and, thus, expected large percentage of ventricular pacing. Exclusion Criteria: * recent acute myocardial infarction (AMI) * coronary artery bypass graft (CABG) (\<3 months) * life expectancy \<2 years, patients in hemodialysis * treatment with a cardiac implantable electronic device (CIED) is contraindicated. * Patients are excluded with regards to the MRI sub study if eGFR \> 35 ml/min, in case or contrast allergy or certain metal implants.
Where it's running
-
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark Recruiting -
Dept. of Cardiology, Aarhus University Hospital, Aarhus
Aarhus, Denmark Not yet recruiting -
Dept of Cardiology, Meilahti Hospital, Helsinki
Helsinki, Finland Not yet recruiting -
Haukeland Universitetssykehus
Bergen, Norway Not yet recruiting -
Sahlgrenska University Hospital
Gothenburg, Sweden Not yet recruiting
Study contacts
- Principal investigator: Niels Risum Risum, MD, PhD — Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- Study coordinator: Niels Risum, MD, PhD
- Email: niels.risum.01@regionh.dk
- Phone: 0045 35456995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pacing decisions guided by risk for pacing-induced heart muscle weakness
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing two pacing methods for heart failure patients
This study is testing whether a new pacing method called conduction system pacing can help heart failure patients just as much as the standard biventricular pacing to improve their heart function.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.